Evaluation of Blood Flow in Pancreatic Ductal Carcinoma Using Contrast-Enhanced, Wide-Band Doppler Ultrasonography: Correlation with Tumor Characteristics and Vascular Endothelial Growth Factor

Pancreas

Volumn 28, Issue 3, 2004, Pages 335-343

  Ohshima, Tadashi ^a,c   Yamaguchi, Taketo ^a   Ishihara, Takeshi ^a   Yoshikawa, Masaharu ^a   Kobayashi, Akitoshi ^a   Sakaue, Nobuyuki ^a   Baba, Takeshi ^a   Yamada, Syuji ^b   Saisho, Hiromitsu ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c NONE   (Japan)

Author keywords

Levovist; Liver metastasis; Pancreatic carcinoma; Vascular endothelial growth factor; Wide band Doppler ultrasonography

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; CONTRAST RADIOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PANCREAS BLOOD FLOW; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS DUCTAL CARCINOMA; PATIENT CODING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; REGIONAL BLOOD FLOW; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1842482972     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200404000-00024     Document Type: Article

References (50)

1. Stuhrmann M, Aronius R, Schietzel M. Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced Doppler sonography. AJR Am J Roentgenol. 2000;175:1585-1589.
2. Sedelaar MJP, Leenders GJLH, Kaa CAHD, et al. Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer. Eur Urol. 2001;40:285-293.
3. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1995;147:9-19.
4. Ellis LM, Takahashi Y, Fenoglio CJ, et al. Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. Eur J Cancer. 1998;34:337-340.
5. Cheng WF, Lee CN, Chu JS, et al. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma. Cancer. 1999;85:651-657.
6. Takebayashi Y, Akiyama S, Yamada K, et al. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer. 1996; 78:226-231.
7. Linder S, Blåsjö M, Rosen A, et al. Pattern of distribution and prognostic value of angiogenesis in pancreatic duct carcinoma. Pancreas. 2001;22: 240-247.
8. Seo Y, Baba H, Fukuda T, et al. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer. 2000;88:2239-2245.
9. Itakura J, Ishiwata T, Friess H, et al. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res. 1997;3:1309-1316.
10. Yamanaka Y, Friess H, Buchler M, et al. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlate with advanced tumor stage. Cancer Res. 1993;53:5289-5296.
11. Rickes S, Ocran K, Neye H, et al. Evaluierung dopplersonographischer Kriterien zur Differential diagnostik von Pankreastumoren. Ultraschall Med. 2000;21:253-258.
12. Schrope B, Newhouse VL, Uhlendorf V. Simulated capillary blood flow measurement using a nonlinear ultrasonic contrast agent. Ultrason Imaging. 1992;14:134-158.
13. Goldberg BB, Liu JB, Bums PN, et al. Galactose-based intravenous sonographic contrast agent: experimental studies. J Ultrasound Med. 1993;12: 463-470.
14. Calliada F, Campani R, Bottinelli O, et al. Ultrasound contrast agents: basic principles. Eur J Radiol. 1998;27:S157-S160.
15. Delorme S, Peschke P, Zuna I, et al. Sensitivity of color Doppler sonography: an experimental approach. Ultrasound Med Biol. 1999;25:541-547.
16. Petrick J, Zomack M, Schlief R. An investigation of the relationship between ultrasound echo enhancement and Doppler frequency shift using a pulsatile arterial flow phantom. J Invest Radiol. 1997;32:225-235.
17. Kono Y, Moriyasu F, Mine Y, et al. Gray scale second harmonic imaging of the liver with galactose-based microbubbles. Invest Radiol. 1997;32: 120-125.
18. Forsberg F, Goldberg BB, Liu JB, et al. On the feasibility of real time, in vivo harmonic imaging with proteinaceous microspheres. J Ultrasound Med. 1996;15:853-860.
19. Choi BI, Kim TK, Han JK, et al. Vascularity of hepatocellular carcinoma: assessment with contrast enhanced second-harmonic versus conventional power Doppler US. Radiology. 2000;214:381-386.
20. Kim TK, Han JK, Kim AY, et al. Limitations of characteristics of hepatic hemangiomas using a sonographic contrast agent (Levovist) and power Doppler ultrasonography. J Ultrasound Med. 1999;18:737-743.
21. Albrecht T, Hoffmann CW, Schettler S, et al. B-mode enhancement at phase-inversion US with air-based microbubble contrast agent: initial experience in humans. Radiology. 2000;216:273-278.
22. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. J Invest Radiol. 2000;35:58-71.
23. Bauer A, Hauff P, Lazenby J, et al. Wideband harmonic imaging: a novel contrast ultrasound imaging technique. Eur Radiol. 1999;3(suppl): S364-S367.
24. Kim TK, Choi BI, Han JK, et al. Hepatic tumors: contrast agent-enhancement patterns with pulse inversion harmonic US. Radiology. 2000;216:411-417.
25. Koito K, Hirokawa N, Ichimura T, et al. Pancreatic tumors: diagnosis with contrast-enhanced sonography by using wide band Doppler technology. Ultrasound Med Biol. 2003;29(suppl 5):S165-166.
26. Sobin LH, Wittekind C, eds. UICC TNM Classification of malignant tumours. 5th ed. New York: John Wiley & Sons, 1997.
27. Köppel G, Solcia E, Longnecker DS, et al. Histological typing of tumors of the exocrine pancreas. World Health Organization. 2nd ed. Berlin: Springer-Verlag, 1996:15-21.
28. Kido S, Kitadai Y, Hattori N, et al. Interleukin8 and vascular endothelial growth factor - prognostic factors in human gastric carcinomas? Eur J Cancer. 2001;137:1482-1487.
29. Tomisaki S, Ohno S, Ichiyoshi Y, et al. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer. 1996; 77(suppl 8):1722-1728.
30. Ueda T, Oda T, Kinoshita T, et al. Neovascularization in Pancreatic ductal adenocarcinoma: microvessel count analysis, comparison with non-cancerous regions and other types of carcinomas. Oncol Rep. 2002;9:239-245.
31. Lu DSK, Vedantham S, Krasny RM, et al. Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas and vascular structures. Radiology. 1996;199:697-701.
32. Furukawa H, Takayasu K, Mukai K, et al. Late contrast-enhanced CT for small pancreatic carcinoma: delayed enhanced area on CT with histopathological correlation. Hepatogastroenterology. 1996;43:1230-1237.
33. Keogan MT, McDermottt VG, Paulson EK, et al. Pancreatic malignancy: effect of dual-phase helical CT in tumor detection and vascular opacification. Radiology. 1997;205:513-518.
34. Freeny PC, Marks WM, Ryan JA, et al. Pancreatic ductal adenocarcinoma: diagnosis and staging with dynamic CT. Radiology. 1988;166: 125-133.
35. Tylén U. Accuracy of angiography in the diagnosis of carcinoma of the pancreas. Acta Radiol. 1973;14:449-466.
36. Chen CN, Cheng YM, Lin MT, et al. Association of color Doppler vascularity index and microvessel density with survival in patients with gastric cancer. Ann Surg. 2002;235:512-518.
37. Kawasaki T, Ueo T, Itani T, et al. Vascularity of advanced gastric carcinoma: evaluation by using power Doppler imaging. J Gastroenterol Hepatol. 2001;16:149-153.
38. Chen CN, Cheng YM, Liang JT, et al. Color Doppler vascularity index can predict distant metastasis and survival in colon cancer patients. Cancer Res. 2000;60:2892-2897.
39. Lassau N, Paturel-asselin C, Guinebretiere JM, et al. New hemodynamic approach to angiogenesis: color and pulsed Doppler ultrasonography. J Invest Radiol. 1999;34:194-198.
40. Lassau N, Koscielny S, Opolon P, et al. Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo. J Invest Radiol. 2001;36:50-55.
41. Uzawa M, Karasawa E, Sugiura N, et al. Doppler color flow imaging in the detection and quantitative measurement of the gastroduodenal artery blood flow. J Clin Ultrasound. 1993;21:9-17.
42. Tomiyama T, Ueno N, Tano S, et al. Assessment of arterial invasion in pancreatic cancer using color Doppler ultrasonography. Am J Gastroenterol. 1996;91:1410-1416.
43. Koito K, Namieno T, Nagakawa T, et al. Inflammatory pancreatic masses: differentiation from ductal carcinomas with contrast-enhanced sonography using carbon dioxide microbubbles. AJR Am J Roentgenol. 1997; 169: 1263-1267.
44. Kato T, Tsukamoto Y, Naitoh Y, et al. Ultrasonographic and endoscopic ultrasonographic angiography in pancreatic mass lesions. Acta Radiol. 1995;36:381-387.
45. Oshikawa O, Tanaka S, Ioka T, et al. Dynamic sonography of pancreatic tumors: comparison with dynamic CT. AJR Am J Roentgenol. 2002;178: 1133-1137.
46. Kim AY, Choi BI, Kim TK, et al. Hepatocellular carcinoma: power Doppler US with a contrast agent - preliminary results. Radiology. 1998;209: 135-140.
47. Forsberg F, Liu JB, Bums PN, et al. Artifacts in ultrasonic contrast agent studies. J Ultrasound Med. 1994;13:357-365.
48. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27-31.
49. Fujioka S, Yoshida K, Yanagisawa S, et al. Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival. Cancer. 2001;92:1788-1797.
50. Teraoka H, Sawada T, Nishihara T, et al. Enhanced VEGF expression and decreased immunogenicity induced by TGF-beta1 promote liver metastasis of pancreatic cancer. Br J Cancer. 2001;85:612-617.